Safety Auxiliary Feedback Element for the Artificial Pancreas in Type 1 Diabetes

The artificial pancreas aims at the automatic delivery of insulin for glycemic control in patients with type 1 diabetes, i.e., closed-loop glucose control. One of the challenges of the artificial pancreas is to avoid controller overreaction leading to hypoglycemia, especially in the late postprandial period. In this study, an original proposal based on sliding mode reference conditioning ideas is presented as a way to reduce hypoglycemia events induced by a closed-loop glucose controller. The method is inspired in the intuitive advantages of two-step constrained control algorithms. It acts on the glucose reference sent to the main controller shaping it so as to avoid violating given constraints on the insulin-on-board. Some distinctive features of the proposed strategy are that 1) it provides a safety layer which can be adjusted according to medical criteria; 2) it can be added to closed-loop controllers of any nature; 3) it is robust against sensor failures and overestimated prandial insulin doses; and 4) it can handle nonlinear models. The method is evaluated in silico with the ten adult patients available in the FDA-accepted UVA simulator.

[1]  R. Hovorka.  Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[2]  Z Trajanoski,et al.  Pharmacokinetic Model for the Absorption of Subcutaneously Injected Soluble Insulin and Monomeric Insulin - Analogues - Pharmakokinetisches Modell für die Absorption von subkutan injiziertem löslichem Insulin und monomeren Insulinanaloga , 1993, Biomedizinische Technik. Biomedical engineering.

[3]  Martin Buss,et al.  Invariance control for a class of cascade nonlinear systems , 2002, IEEE Trans. Autom. Control..

[4]  J. Stockman,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2011 .

[5]  Lutz Heinemann,et al.  Insulin Pump Therapy: What is the Evidence for Using Different Types of Boluses for Coverage of Prandial Insulin Requirements? , 2009, Journal of diabetes science and technology.

[6]  H. Amann,et al.  Ordinary Differential Equations: An Introduction to Nonlinear Analysis , 1990 .

[7]  S. Tarbouriech,et al.  Anti-windup design: an overview of some recent advances and open problems , 2009 .

[8]  Howard C. Zisser,et al.  A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus. , 2008, Journal of process control.

[9]  Howard C. Zisser,et al.  Fully Integrated Artificial Pancreas in Type 1 Diabetes , 2012, Diabetes.

[10]  Malgorzata E. Wilinska,et al.  Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin , 2005, IEEE Transactions on Biomedical Engineering.

[11]  Fabricio Garelli,et al.  Variable structure strategy to avoid amplitude and rate saturation in pitch control of a wind turbine , 2010 .

[12]  G. Boden,et al.  Effects of Age and Body Fat Insulin Resistance in Healthy Men , 1993, Diabetes Care.

[13]  Yuri B. Shtessel,et al.  Blood Glucose Regulation via Double Loop Higher Order Sliding Mode Control and Multiple Sampling Rate , 2008 .

[14]  B. J. Winer.  Statistical Principles in Experimental Design , 1992 .

[15]  Stephen D Patek,et al.  Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data , 2010, Journal of diabetes science and technology.

[16]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[17]  Jesús Picó,et al.  Sliding mode reference conditioning for coordination in swarms of non-identical multi-agent systems , 2012, 2012 12th International Workshop on Variable Structure Systems.

[18]  L. Magni,et al.  Model Predictive Control of Type 1 Diabetes: An in Silico Trial , 2007, Journal of diabetes science and technology.

[19]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[20]  Jan Sternby,et al.  Conditioning technique for multiinput-multioutput processes with input saturation , 1993 .

[21]  M. Shichiri,et al.  Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. , 1997, Frontiers of medical and biological engineering : the international journal of the Japan Society of Medical Electronics and Biological Engineering.

[22]  W. Kenneth Ward,et al.  Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.

[23]  Roman Hovorka,et al.  The future of continuous glucose monitoring: closed loop. , 2008, Current diabetes reviews.

[24]  Eyal Dassau,et al.  Bolus calculator: a review of four "smart" insulin pumps. , 2008, Diabetes technology & therapeutics.

[25]  Roman Hovorka,et al.  Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes , 2010, Journal of diabetes science and technology.

[26]  Manfred Morari,et al.  A unified framework for the study of anti-windup designs , 1994, Autom..

[27]  Peter Arner,et al.  Use of waist circumference to predict insulin resistance: retrospective study , 2005, BMJ : British Medical Journal.

[28]  Fabricio Garelli,et al.  Limiting interactions in decentralized control of MIMO systems , 2006 .

[29]  T. Bailey,et al.  Guidelines for Optimal Bolus Calculator Settings in Adults , 2011, Journal of diabetes science and technology.

[30]  C. Cobelli,et al.  Artificial Pancreas: Past, Present, Future , 2011, Diabetes.

[31]  Cesar C. Palerm,et al.  Physiologic insulin delivery with insulin feedback: A control systems perspective , 2011, Comput. Methods Programs Biomed..

[32]  Darine Zambrano,et al.  A robust sliding mode controller with internal model for closed-loop artificial pancreas , 2010, Medical & Biological Engineering & Computing.

[33]  T. Klupa,et al.  Clinical Usefulness of a Bolus Calculator in Maintaining Normoglycaemia in Active Professional Patients with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion , 2008, The Journal of international medical research.

[34]  Anirban Roy,et al.  The effect of insulin feedback on closed loop glucose control. , 2011, The Journal of clinical endocrinology and metabolism.

[35]  David Q. Mayne,et al.  Constrained model predictive control: Stability and optimality , 2000, Autom..

[36]  Ricardo Femat,et al.  Fuzzy-Based Controller for Glucose Regulation in Type-1 Diabetic Patients by Subcutaneous Route , 2006, IEEE Transactions on Biomedical Engineering.

[37]  Michel Kinnaert,et al.  Conditioning technique, a general anti-windup and bumpless transfer method , 1987, Autom..

[38]  G. Moneta,et al.  Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes , 2007 .

[39]  L. Magni,et al.  Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier , 2009, Journal of diabetes science and technology.

[40]  John Walsh,et al.  Guidelines for Insulin Dosing in Continuous Subcutaneous Insulin Infusion Using New Formulas from a Retrospective Study of Individuals with Optimal Glucose Levels , 2010, Journal of diabetes science and technology.

[41]  Pedro Albertos,et al.  Sliding mode speed auto-regulation technique for robotic tracking , 2011, Robotics Auton. Syst..

[42]  Francis J. Doyle,et al.  Robust H∞ glucose control in diabetes using a physiological model , 2000 .

[43]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[44]  D Rodbard,et al.  Computer Simulation of Plasma Insulin and Glucose Dynamics After Subcutaneous Insulin Injection , 1989, Diabetes Care.

[45]  B. Bequette.  A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[46]  E. Lightfoot,et al.  A model for multiple subcutaneous insulin injections developed from individual diabetic patient data. , 1995, The American journal of physiology.

[47]  D. James,et al.  Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. , 1985, The American journal of physiology.

[48]  Eyal Dassau,et al.  Safety Constraints in an Artificial Pancreatic β Cell: An Implementation of Model Predictive Control with Insulin on Board , 2009, Journal of diabetes science and technology.

[49]  T. Kobayashi,et al.  The Pharmacokinetics of Insulin After Continuous Subcutaneous Infusion or Bolus Subcutaneous Injection in Diabetic Patients , 1983, Diabetes.

[50]  Daniel U. Campos-Delgado,et al.  Extension of the run-to-run control to multi-boluses schemes , 2008, 2008 IEEE International Conference on Control Applications.

[51]  Jesús Picó,et al.  Geometric invariance and reference conditioning ideas for control of overflow metabolism , 2009 .

[52]  Yogish C Kudva,et al.  Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. , 2009, The Journal of clinical endocrinology and metabolism.

[53]  Ewa Pańkowska,et al.  Bolus Calculator with Nutrition Database Software, a New Concept of Prandial Insulin Programming for Pump Users , 2010, Journal of diabetes science and technology.

[54]  Jesús Picó,et al.  Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations , 2005, IEEE Transactions on Biomedical Engineering.

[55]  M W Percival,et al.  Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parameters. , 2011, Journal of process control.

[56]  Manfred Morari,et al.  Some Control Problems in the Process Industries , 1993 .

[57]  Geremia B Bolli.  Insulin treatment in type 1 diabetes. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[58]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[59]  S. Patek,et al.  Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience , 2009, Journal of diabetes science and technology.

[60]  Raymond Hanus,et al.  Anti-windup, bumpless, and conditioned transfer techniques for PID controllers , 1996 .

[61]  Darrell M. Wilson,et al.  A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.

[62]  Christopher Edwards,et al.  Sliding mode control : theory and applications , 1998 .

[63]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[64]  E. Haus,et al.  Chronobiology in the endocrine system. , 1989, Advanced drug delivery reviews.

[65]  Xing-Wei Wong,et al.  Model-Based Therapeutics for Type 1 Diabetes Mellitus , 2008 .

[66]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[67]  Yang Kuang,et al.  Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes. , 2008, Mathematical biosciences and engineering : MBE.